University of California, San Diego
La Jolla, California, 92093, United States
NCT Number: NCT03533023
This is the first study of its kind to assess and test an intervention to improve biological rhythms and general health of shift workers, specifically first responders with San Diego Fire and Rescue. In a randomized control trial, investigators intend to measure the health impact of Time Restricted Eating in emergency responders who work a 24-hour shift schedule.
Looking for future studies?
Notify Me21 year–65 year
All sexes
Interventional
Not applicable
La Jolla, California, 92093, United States
Participants will be randomly assigned to a control group of behavioral nutrition counseling (standard of care) or the intervention group of standard of care with the addition of adopting a 10 hour eating window for one year (TRE). For the first 3 months of intervention, participants will be monitored closely by the research team. For the following 9 months, participants will be in a self-monitored intervention period. Investigators will evaluate the impact of TRE on blood glucose levels, biomarkers, sleep/mood, and weight loss. These assessments will be made at baseline, at the end of the 12-week monitored intervention period, and every 3 months (months 6, 9, and 12) during the self-monitored intervention period for one year. Food/drink intake, activity, and sleep will be monitored with the smartphone myCircadianClock application ("mCC app") throughout the study. A continuous glucose monitor, a wrist-worn actigraphy device, and questionnaires will also be used during the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
As per recommendations from the fire department, fire department unions, and funding agencies, we did not require compromised health measures (e.g. hyperglycemia, hypertension, etc.) as inclusion criteria for they would be discriminatory against some firefighters.
Inclusion criteria
Exclusion criteria
Participants in this arm will adhere to a daily, consistent 10-hr eating window for the course of the study as well as receive nutritional counseling from the study dietician.
Other names: Time Restricted Eating
Participants in this arm will receive nutritional counseling from the study dietician, but will not be required to adopt a 10-hr eating window.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured by an ambulatory continuous glucose monitoring device and blood work throughout the study.
Note: Significant changes expected in participants who had elevated glucose homeostasis at baseline. No significant changes expected in those within normal ranges at baseline. Primary endpoint analysis will be done by comparing baseline and 12-week intervention.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured by percentage of days logged that participants ate within their 10-hour window and by end of study responses.
Note: Significant changes expected in participants in the TRE arm of the study on and off shift. No significant changes expected in the standard of care arm of the study. Primary endpoint analysis will be done by comparing baseline and 12-week intervention.
Time frame: Timeframe: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured with blood biochemistry.Measured with blood biochemistry under TRE, including, but not limited to: fasting glucose, HbA1c, cholesterol, and triglycerides.
Note: Significant changes expected in participants who had abnormal levels at baseline (e.g. elevated LDL cholesterol, low HDL cholesterol, elevated triglycerides). No significant changes expected in those were within normal ranges at baseline.
Time frame: Timeframe: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured at baseline and during TRE intervention. Note: Significant changes expected in participants who had elevated systolic blood pressure at baseline. No significant changes expected in those without elevated systolic blood pressure at baseline.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured at baseline and during TRE intervention. Note: Significant changes expected in participants who had elevated diastolic blood pressure at baseline. No significant changes expected in those without elevated diastolic blood pressure at baseline.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured on a digital scale. Note: Significant changes expected in participants who had elevated weight at baseline. No significant changes expected in those who were not overweight at baseline.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Calculated from body weight (kg) and height (m). Note: Significant changes expected in participants who had elevated BMI at baseline. No significant changes expected in those whose BMI was not elevated at baseline.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured with standardized body tape measure. Note: Significant changes expected in participants who had increased waist and hip circumference at baseline. No significant changes expected in those without increased waist and hip circumference at baseline.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured using tape measure. Note: Significant changes expected in participants who had an increased hip/waist ratio at baseline. No significant changes expected in those without increases at baseline
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured by Tanita Digital Scale. Note: Significant changes expected in participants who had elevations levels at baseline. No significant changes expected in those without elevations at baseline.
Time frame: primary endpoint=12-week intervention (compared to 2-week baseline); follow-up will be at 1-year
Measured by SF-36, PSQI, and ESS. Note: Significant changes expected in participants who had decreased self-reporting of the above-mentioned questionnaires at baseline. No significant changes expected in those without decreases at baseline.
University of California, San Diego
Other
Optimizing Circadian Rhythms by Regulating Eating Patterns to Reduce Cardiometabolic Disease Risk Among Firefighters--The Healthy Heroes Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06527703
Arterial Occlusive Diseases, Arteriosclerosis
San Ġiljan, Msida, Malta
View Trial DetailsNCT04499599
Behavior, Fasting
Los Angeles, California, United States
View Trial DetailsNCT04247464
Behavior, Colonic Diseases
Madrid, Spain
View Trial DetailsNCT04266015
Atrophy, Behavior
Yanchao, Kaohsiung, Taiwan
View Trial Details